Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
FDA unveils new pathway to speed custom gene editing therapies
Called the “plausible mechanism pathway,” the program is designed to offer a new way to market for personalized therapies, FDA officials said.
Angus Liu
Nov 12, 2025 5:00pm
Sponsored
Medicus pharma advances Teverelix in prostate cancer and urology
Nov 10, 2025 8:00am
nChroma Bio sheds staff in research reorganization
Nov 12, 2025 5:31pm
Sponsored
Addressing Choline Deficiency in Parenteral Nutrition Patients
Nov 10, 2025 8:00am
Korro lays off staff as lead drug disappoints, Novo pauses pact
Nov 13, 2025 7:20am
Novartis' resistance-busting malaria drug hits phase 3 goal
Nov 13, 2025 7:05am
More News
Fierce Healthcare
Government shutdown updates: Trump signs bill ending shutdown
Nov 12, 2025 11:00pm
AbbVie to end Calico collab, lay off scientists: Stat
Nov 12, 2025 2:51pm
BMS boosts cancer trials with Sarah Cannon’s platform
Nov 12, 2025 12:30pm
Fierce Biotech Layoff Tracker 2025: nChroma, Metagenomi & more
Nov 12, 2025 12:00pm
See more stories
